Cresco Labs (CRLBF) Cash from Financing Activities (2019 - 2025)

Cresco Labs (CRLBF) reported Cash from Financing Activities of -$1.8 million for Q4 2025, up 95.73% on a YoY basis from -$916037.2 in Q4 2024, and up 97.48% quarter-over-quarter from -$71.1 million in Q3 2025.

Cresco Labs (CRLBF) Cash from Financing Activities (2019 - 2025) Analysis & Trends

Cresco Labs has reported Cash from Financing Activities for 7 years, with the latest figure at -$1.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 95.73% year-over-year to -$1.8 million; the trailing twelve-month figure through Dec 2025 stood at -$117.4 million (down 207.07% YoY), and the FY2025 full-year result was -$82.1 million, down 14.84% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at -$1.8 million, up from -$71.1 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $155.9 million in Q3 2021, with the low at -$71.1 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged $9.4 million across 5 years, with a median of -$2.4 million in 2021.
  • Annual changes were most pronounced in 2021 — Cash from Financing Activities soared 1057.69% — and 2025, when it sank 2785.39%.
  • Cresco Labs' Cash from Financing Activities stood at -$2.4 million in 2021, then rose by 14.48% to -$2.0 million in 2022, then slumped by 86.21% to -$3.8 million in 2023, then sank by 1011.42% to -$42.0 million in 2024, then soared by 95.73% to -$1.8 million in 2025.
  • The last three Cash from Financing Activities figures came in at -$1.8 million (Q4 2025), -$71.1 million (Q3 2025), and -$42.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Cresco Labs - - 75.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.79 Mn
Dec 31, 2025 -1.79 Mn
Sep 30, 2025 -71.10 Mn
Sep 30, 2025 -71.10 Mn
Dec 31, 2024 -42.03 Mn
Dec 31, 2024 -42.03 Mn
Sep 30, 2024 -2.46 Mn
Sep 30, 2024 -2.46 Mn
Dec 31, 2023 -3.78 Mn
Dec 31, 2023 -3.78 Mn
Sep 30, 2023 10.05 Mn
Sep 30, 2023 10.05 Mn
Dec 31, 2022 -2.03 Mn
Dec 31, 2022 -2.03 Mn
Sep 30, 2022 -9.11 Mn
Sep 30, 2022 -9.11 Mn
Dec 31, 2021 -2.38 Mn
Dec 31, 2021 -2.38 Mn
Sep 30, 2021 155.86 Mn
Sep 30, 2021 155.86 Mn